CIDRAP newsletters options
Studies look at COVID-19 immune responses in pregnant women.
For the third week in a row, illness numbers in Europe rose, with a 7% jump last week.
Two large studies show very high protection against the more transmissible variant.
COVID-19 outpatients were more likely to have more respiratory symptoms if they were overweight or obese, according to a study published yesterday in Influenza and Other Respiratory Viruses.
"Learnings from negative trials such as this are important."
The FDA may approve "mix and match" boosters, meaning different ones from the vaccine originally received.
The antibiotic SUL-DUR stacked up well to colistin for 28-day mortality and outperformed it for clinical cure rate and kidney harm.
France-based Valneva reports positive results for its vaccine compared with the AstraZeneca vaccine.
COVID-19 patients with immune-mediated inflammatory diseases (IMIDs) may benefit from tumor necrosis factor (TNF) inhibitors, according to a study published yesterday in JAMA Network Open.
Cold weather is likely driving more people inside in those states, leading to heightened virus transmission.
Out-of-pocket costs could range from $1,500 to $3,800, depending on insurance.
Elsewhere, countries in Eastern Europe are fighting surges, including Russia, Romania, Hungary, and Latvia.
SARS-CoV-2 dose may affect infection rates, but current data do not show an association between viral dose and COVID-19 severity, according to a review of more than 100 SARS-CoV-2 studies that looks at COVID-19 infectious dose, viral load, severity, and variants.
Three more Ebola cases, one of them fatal, were reported in the Democratic Republic of the Congo's (DRC's) latest resurgence near Beni in North Kivu province, according to a World Health Organization (WHO) DRC office tweet today. The case total is now five including three deaths, said the World Health Organization (WHO) African regional office today on Twitter.
For the roughly 14 million Americans who have received one J&J dose, the booster should be given at least 2 months later.
Experts detail the necessary elements of a rigorous mask study and explore some recent studies that, though highly touted by both scientists and the lay press, fell quite a bit short.
Also, vaccine mandates hit some snags as the rate of Americans getting booster shots nears 5%.
"Unfortunately, the public health workers who are the most experienced are also the ones who are the most burned out."
A 17-study literature review looking at vaccine effectiveness (VE) during the Delta (B1617.2) variant shows a pooled VE of 90.9% versus hospitalization with a 75.7% and 63.1% VE against symptomatic and asymptomatic infection, respectively.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
